Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contrast-Enhanced Ultrasound for Acute Appendicitis
NCT03295656Phase 1Withdrawn
- Sponsor
- Boston Children's Hospital
- Start
- Jul 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sulfur hexafluoride in acute appendicitis, sponsored by Boston Children's Hospital. Primary endpoint: Contrast-enhanced ultrasound diagnosis of acute appendicitis at 1 week. Planned start Jul 2020; status: withdrawn.
02
Drugs
sulfur hexafluoride
03
Conditions
acute appendicitis
Beyond the preview
Go deeper on NCT03295656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03295656.